Science and Research

Low-protein diet applied as part of combination therapy or stand-alone normalizes lifespan and tumor proliferation in a model of intestinal cancer

Tumors of the intestinal tract are among the most common tumor diseases in humans, but, like many other tumor entities, show an unsatisfactory prognosis with a need for effective therapies. To test whether nutritional interventions and a combination with a targeted therapy can effectively cure these cancers, we used the fruit fly Drosophila as a model. In this system, we induced tumors by EGFR overexpression in intestinal stem cells. Limiting the amount of protein in the diet restored life span to that of control animals. In combination with a specific EGFR inhibitor, all major tumor-associated phenotypes could be rescued. This form of treatment was also successful in a real treatment scenario, which means when they started after the full tumor phenotype was expressed. In conclusion, reduced protein administration can be a very promising form of adjuvant cancer therapy.

  • Proske, A.
  • Bossen, J.
  • von Frieling, J.
  • Roeder, T.

Keywords

  • Drosophila
  • Egfr
  • afatinib
  • cancer
  • dietary protein restriction
  • stem cells
Publication details
DOI: 10.18632/aging.203692
Journal: Aging (Albany NY)
Number: undefined
Work Type: Original
Location: ARCN
Disease Area: LC
Partner / Member: CAU
Access-Number: 34766923

DZL Engagements

chevron-down